The ESTIV Members AreaThe new Biomedical research report from ECVAM is out: https://ec.europa.eu/jrc/en/science-update/tackling-neurodegenerative-diseases-more-human-relevant-research.
3 May 2021
The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research
Related content
The ESTIV 2026 Special Issue is open for submissions
Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.
ESTIV: ERA4NAMs Survey – request for contribution
The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.
The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress
The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.
Silver Sponsor
Corporate Members
Communication partners
Memorandum of Understanding
